neorecormon 10000 ui/0,6ml
roche pharma ag - germania - epoetinum beta - sol. inj. in seringa preumpluta - 10000ui/0,6ml - alte preparate antianemice alte preparate antianemice
neorecormon 2000 ui/0,3ml
roche pharma ag - germania - epoetinum beta - sol. inj. in seringa preumpluta - 2000ui/0,3ml - alte preparate antianemice alte preparate antianemice
neorecormon 30000 ui/0,6ml
roche pharma ag - germania - epoetinum beta - sol. inj. in seringa preumpluta - 30000 ui/0,6ml - alte preparate antianemice alte preparate antianemice
neorecormon 4000 ui/0,3ml
roche pharma ag - germania - epoetinum beta - sol. inj. in seringa preumpluta - 4000ui/0,3ml - alte preparate antianemice alte preparate antianemice
neorecormon 5000 ui/0,3ml
roche pharma ag - germania - epoetinum beta - sol. inj. in seringa preumpluta - 5000ui/0,3ml - alte preparate antianemice alte preparate antianemice
ocrevus 300 mg
roche pharma ag - germania - ocrelizumab - conc. pt. sol. perf. - 300mg - imunosupresoare imunosupresoare selective
perjeta 420mg
roche pharma ag - germania - pertuzumabum - conc. pt. sol. perf. - 420mg - anticorpi monoclonali
phesgo 1200 mg/600 mg
roche pharma ag - germania - combinatii (pertuzumabum+trastuzumabum) - sol. inj. - 1200mg/600mg - alte antineoplazice alte antineoplazice in combinatie
polivy 140mg
roche pharma ag - germania - polatuzumab brentuximab - pulb. pt. conc. pt. sol. perf. - 20mg/ml - anticorpi monoclonali si conjugati anticorp medicament
polivy 30mg
roche pharma ag - germania - polatuzumab brentuximab - pulb. pt. conc. pt. sol. perf. - 20mg/ml - anticorpi monoclonali si conjugati anticorp medicament